Recent 8-K filings for CURLF

• September 16, 2026, 12:29 PM ET M&A materiality 1.00 positive item 8.01item 9.01

  Curaleaf urges Aurora shareholders to tender at $4.00/share, 45% premium

  Offer: 0.3463 Curaleaf shares + US$0.75 cash per Aurora share, implying US$4.00 vs US$2.76 pre-offer (45% premium).

• September 15, 2026, 3:56 PM ET M&A materiality 0.85 positive item 8.01item 9.01

  Curaleaf urges Aurora shareholders to tender; touts 45% premium, $4.00 offer

  Offer of 0.3463 Curaleaf shares + $0.75 cash per Aurora share implies $4.00 price, 45% premium to $2.76.

• September 14, 2026, 3:30 PM ET M&A materiality 0.80 positive item 8.01item 9.01

  Curaleaf asks Alberta regulator to halt Aurora's ATM share sales during US$4.00/share offer

  Filed application with Alberta Securities Commission to stop Aurora's ATM issuances during pending US$4.00/share offer.

• September 8, 2026, 5:08 PM ET M&A materiality 0.80 positive item 8.01item 9.01

  Curaleaf fact sheet defends 45% premium offer for Aurora, rebuts criticisms

  Offer represents 45% premium (~110% ex-cash); US$5.00 cap in 92nd percentile of Canadian M&A premiums.

• September 2, 2026, 1:15 PM ET M&A materiality 0.80 neutral item 8.01item 9.01

  Curaleaf defends 45% premium offer for Aurora, attacks Aurora's dilution and cash burn

  Curaleaf reaffirms hostile offer for Aurora, citing 45% premium (110% ex-cash) and $5 cap (82% premium to Aug 10 VWAP).

• August 24, 2026, 6:55 PM ET M&A materiality 0.90 positive item 8.01item 9.01

  Curaleaf rebuts Aurora's claims, cites 35% share decline and weak EBITDA

  Aurora shares fell ~35% over past year vs Curaleaf +56%; Curaleaf reiterates substantial premium offer.

• August 18, 2026, 9:16 AM ET M&A materiality 0.90 positive item 8.01item 9.01

  Curaleaf launches formal take-over bid for Aurora Cannabis at $4.00/share, 45% premium

  Offer: 0.3463 Curaleaf shares + US$0.75 cash per Aurora share, total ~US$4.00, 45% premium to unaffected price.

• August 12, 2026, 11:03 AM ET M&A materiality 0.90 positive item 8.01item 9.01

  Curaleaf launches hostile take-over bid for Aurora Cannabis at US$4.00/share, 45% premium

  Offer: 0.3463 Curaleaf shares + US$0.75 cash per Aurora share, total US$4.00; 45% premium to 30-day VWAP of US$2.75.

• August 5, 2026, 10:00 PM ET other materiality 0.00 neutral item 8.01item 9.01

  Curaleaf files 8-K with XBRL data only; no material event disclosed

  Filing contains only XBRL taxonomy references and context IDs, no narrative or press release.

• August 5, 2026, 9:51 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  Curaleaf Q2 2026 revenue $340M (+10% YoY), net income $12.5M, adjusted EBITDA $70M

  Net revenue $340.1M, up 10% YoY from $310.6M; international revenue $51M (+26% YoY).

Earnings & guidance

Materiality & sentiment trend

Max materiality 1.00 · Median 0.82 · Most common event m_and_a

8 positive 0 negative 2 neutral

source · CURLF on sec.gov